Article citationsMore >>

Geller DS, Zhang J, Zennaro MC, Vallo-Boado A, Rodriguez-Soriano J, Furu L, Haws R, Metzger D, Bothlho B, Karaviti L, Haqq AM, Corey H, Janssens S, Carvol P, Lifton RP, “Autosomal dominant pseudohypoaldosteronism type 1: mechanisms, evidence for neonatal lethality, and phenotypic expression in adults,” J Am Soc Nephrol, 17:1429-1436. 2006.

has been cited by the following article:

Article

First-Aid Treatment of Hyperkalemia by Nebulised Salbutamol: An Experience in Pseudohypoaldosteronism

1Department of Pediatrics, Kansai Medical University, 10-15 Fumizono-cho, Moriguchi, Osaka 570-8506, Japan


American Journal of Medical Case Reports. 2015, Vol. 3 No. 3, 91-92
DOI: 10.12691/ajmcr-3-3-11
Copyright © 2015 Science and Education Publishing

Cite this paper:
Yuichiro Imai, Junji Takaya, Kazunari Kaneko. First-Aid Treatment of Hyperkalemia by Nebulised Salbutamol: An Experience in Pseudohypoaldosteronism. American Journal of Medical Case Reports. 2015; 3(3):91-92. doi: 10.12691/ajmcr-3-3-11.

Correspondence to: Junji  Takaya, Department of Pediatrics, Kansai Medical University, 10-15 Fumizono-cho, Moriguchi, Osaka 570-8506, Japan. Email: takaya@kawati.or.jp

Abstract

In the present case with primary pseudohypoaldosteronism, severe hypekalemia was treated with salbutamol inhalation in acute phase. Transcellular hypokalemic effect of salbutamol is related to the activation of Na-K pump on the cell membrane. Although use of salbutamol inhalation in hyperkalemia was previously described, it has not been widely used. The administration of salbutamol by inhalation is a simple, safe and reasonably effective method for treatment of hyperkalemia even in children.

Keywords